Literature DB >> 28083985

HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection.

E Catamo1, L Zupin2, N Freato3, V Polesello2, F Celsi2, S L Crocè1, F Masutti1, G Pozzato1, L Segat2, S Crovella1,2.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) is able to bypass the immune system modulating innate and adaptive immune response and blocking T helper 1 (Th1) cell production. Because the human leukocyte antigen (HLA)-G molecule has immunomodulatory properties inhibiting the function and production of natural killer and cytotoxic lymphocyte T cells, as well as promoting shift from Th1 toward Th2 response, we hypothesized its involvement in susceptibility to HCV infection.
MATERIALS AND METHODS: Considering that HLA-G mRNA expression has been reported to be under genetic control, an association study was conducted analyzing 800 base pairs upstream the ATG at the 5'upstream regulator region (URR) and 850 base pairs from ATG to exon 3 and the 3'untranslated region (UTR) of HLA-G gene in Italian HCV-positive patients and uninfected controls.
RESULTS: Four 5'URR polymorphisms (-725C>G>T, -509C>G, -400G>A and -398G>A), 7 polymorphisms at coding region (+15G>A, +36G>A, +243G>A, insC506, 531G>C, delA615 and 685G>A), the +644G>T polymorphism, and 1 haplotype (TTGTTCCIGAC) showed different frequency distributions between HCV patients and uninfected controls.
CONCLUSION: The results from our study suggest a possible involvement of HLA-G in the risk modulation toward HCV infection.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatitis C virus; human leukocyte antigen-G; immunity; single nucleotide polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28083985     DOI: 10.1111/tan.12959

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  4 in total

1.  Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.

Authors:  Odilon Nouatin; Ulysse Ateba Ngoa; Javier Ibáñez; Jean Claude Dejon-Agobe; Benjamin Mordmüller; Jean Ronald Edoa; Fabrice Mougeni; Sina Brückner; Aurore Bouyoukou Hounkpatin; Meral Esen; Michael Theisen; Kabirou Moutairou; Stephen L Hoffman; Saadou Issifou; Adrian J F Luty; Marguerite M Loembe; Selidji Todagbé Agnandji; Bertrand Lell; Peter G Kremsner; Ayôla Akim Adegnika
Journal:  Vaccine       Date:  2020-05-05       Impact factor: 3.641

2.  HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.

Authors:  Seik-Soon Khor; Yosuke Omae; Nao Nishida; Masaya Sugiyama; Noriko Kinoshita; Tetsuya Suzuki; Michiyo Suzuki; Satoshi Suzuki; Shinyu Izumi; Masayuki Hojo; Norio Ohmagari; Masashi Mizokami; Katsushi Tokunaga
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

Review 3.  Understanding Immune Responses to Viruses-Do Underlying Th1/Th2 Cell Biases Predict Outcome?

Authors:  Faith H N Howard; Amy Kwan; Natalie Winder; Amina Mughal; Cristal Collado-Rojas; Munitta Muthana
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

4.  The association of HLA-G polymorphism with oral and genital HPV infection in men.

Authors:  Nelli T Suominen; Anna J Jaakola; Michel Roger; Marie-Claude Faucher; Kari J Syrjänen; Seija E Grénman; Stina M Syrjänen; Karolina Louvanto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-10-25       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.